Mutations of the APC, beta-catenin, and axin 1 genes and cytoplasmic accumulation of beta-catenin in oral squamous cell carcinoma Soichi IwaiWataru KatagiriYoshiaki Yura Original Paper 15 September 2005 Pages: 773 - 782
Impact of gefitinib (‘Iressa’) treatment on the quality of life of patients with advanced non-small-cell lung cancer Alain GelibterAnna CeribelliFrancesco Cognetti Original Paper 24 September 2005 Pages: 783 - 788
Jun activation domain-binding protein 1 is required for mitotic checkpoint activation via its involvement in hyperphosphorylation of 53BP1 Hee-Jin KwakSung Hak KimChang-Hun Lee Original Paper 27 September 2005 Pages: 789 - 796
Prognostic significance of CD40 expression in malignant lymphoma developing in rheumatoid arthritis Toru SasakiYoshihiko HoshidaKatsuyuki Aozasa Original Paper 22 September 2005 Pages: 797 - 802
Polymorphism of p16 INK4A and cyclin D1 in adenocarcinomas of the upper gastrointestinal tract Helene GeddertSibylle KielMario Sarbia Original Paper 15 September 2005 Pages: 803 - 808
Coordinate cell-surface expression of matrix metalloproteinases and their inhibitors on cancer-associated myofibroblasts from malignant ascites in patients with gastric carcinoma Shohei Koyama Original Paper 23 September 2005 Pages: 809 - 814
Phase I study of continuous mitomycin-C infusion in concomitant radiochemotherapy of primary inoperable advanced head and neck cancer Hans ChristiansenRobert M. HermannOlivier Pradier Original Paper 02 September 2005 Pages: 815 - 820
Novel DNA amplification on chromosomes 2p25.3 and 7q11.23 in cholangiocarcinoma identified by arbitrarily primed polymerase chain reaction S. ChariyalertsakT. KhuhapremaS. Petmitr Original Paper 23 September 2005 Pages: 821 - 828
Antitumor activity of novel N-sulfonylpyrimidine derivatives on the growth of anaplastic mammary carcinoma in vivo Marina PavlakRanko StojkovićMarko Radačić Original Paper 13 September 2005 Pages: 829 - 836